Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000300836 | SCV000334128 | uncertain significance | not provided | 2015-08-13 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001082628 | SCV000562410 | likely benign | CHARGE association | 2023-08-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000624519 | SCV000742284 | uncertain significance | Inborn genetic diseases | 2017-04-10 | criteria provided, single submitter | clinical testing | Lines of evidence used in support of classification: UNCERTAIN: Alteration(s) of Uncertain Clinical Significance Detected |
Revvity Omics, |
RCV000300836 | SCV003831964 | uncertain significance | not provided | 2021-02-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003920052 | SCV004729887 | uncertain significance | CHD7-related condition | 2024-01-06 | criteria provided, single submitter | clinical testing | The CHD7 c.3241A>G variant is predicted to result in the amino acid substitution p.Ile1081Val. To our knowledge, this variant has not been reported in the literature, but has conflicting interpretations in ClinVar regarding its pathogenicity, ranging from likely benign to variant of uncertain significance (https://www.ncbi.nlm.nih.gov/clinvar/variation/282588/evidence/). This variant is reported in a single heterozygous individual of the "Other" population in gnomAD. An alternate missense alteration at the same amino acid position is classified as Likely Pathogenic in ClinVar by two submitters, with both cases marked as affected individuals, and one case marked as a de novo finding (https://www.ncbi.nlm.nih.gov/clinvar/variation/267424/?oq=267424&m=NM_017780.4(CHD7):c.3241A%3ET%20(p.Ile1081Phe)). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |